Wednesday, June 30, 2010

Hurricane Alex Isn't BP's Only Worry These Days in Gulf Waters

›
BP plc (BP-$28.88) spokesperson Toby Odone acknowledged to reporters last week that the 45-ton blow-out preventer sitting atop the damaged...
Thursday, June 24, 2010

U.S. Drill Plan Impacts Transocean's Drilling Worldwide

›
Transocean’s (RIG - $52.00) ‘at-risk’ contract backlog from U.S. offshore Gulf operations was a nominal 6.4 percent, or $1.8 billion out of...
Wednesday, June 23, 2010

BP's Oil Spill Costs in Gulf Accelerating -- Next Stop: $3.0 Billion

›
British oil major BP (BP-$29.68) said response efforts toward the oil spill in the Gulf of Mexico – including containment, relief well dril...
Friday, June 18, 2010

BP Walking Plank to Insolvency?

›
As of June 14, BP (BP-$31.71) has paid out approximately $1.6 billion – spill response, containment, relief well drilling, grants to affec...
Thursday, June 10, 2010

What Do Supermodel Gisele Bündchen, Suntech Power, and Yingli Green Energy Have in Common?

›
Does anyone remember the good old days – back in 2007 and 2008 – when über-supermodel Gisele Bündchen demanded to be paid in euros? So keen...
Tuesday, June 08, 2010

BP Acting Like Three Stooges -- Why Not Learn From Them, Too?

›
For weeks BP and the White House had confidently told the American public that the oil spewing out of the busted wellbore from the sunken ...

LDK Solar Forecasting Profitable 2010

›
LDK Solar (LDK-$5.10) believes firmer selling prices and falling production costs will help the wafer and module maker repair compressed m...
1 comment:

Eurozone Currency Weakness is Latest Problem for Trina Solar and Other Chinese Module Makers

›
China-based Trina Solar (TSL-$15.73) is a module maker whose currency mismatches are overshadowing planned shipments of 750 MW to 800 MW fo...
Wednesday, June 02, 2010

Pivotal Meeting for Novartis' MS Drug Gilenia Next Week

›
The FDA has extended the review period for Novartis AG’s (NVS-$45.97) investigational multiple sclerosis (MS) drug Gilenia by three months...
Wednesday, May 26, 2010

Financial Transparency and Change Coming to LDK Solar? Thing Again.

›
That LDK Solar (LDK-$5.55) , the world’s largest producer of multicrystalline solar wafers, kept up with most of its peers and blew past co...
Friday, May 21, 2010

Worried About Man-Made Disasters? Avoid Draw Muhammad Day

›
May 20 is being celebrated around the globe -- by infidels -- as " Draw Muhammad Day ." In honor of Draw Muhammad Day, we offer u...
1 comment:
Monday, May 17, 2010

BP Finger-Points Blame on Transocean

›
Although the investigation into the oil spill disaster in the Gulf of Mexico is still in the early stages, standard industry practice is su...
Thursday, May 13, 2010

National Enquirer Offers Million Dollar Bounty For Alleged Obama Love Tryst Video

›
In March 2010, average weekly print circulation — newsstand and subscription — of the National Enquirer declined year-over-year 16.1 perce...
2 comments:
Tuesday, May 11, 2010

More Calls For CEO Blankenship's Resignation at Massey Energy

›
It has become a ritual at Massey Energy’s (MEE-$35.77) annual shareholder meeting for interest groups to stage protests and call for the re...
Friday, May 07, 2010

"Spill, Baby, Spill" - Or Not, Says BP

›
British energy giant BP ($49.78) initially accepted responsibility for the April 5 explosion aboard the offshore drilling rig Deepwater Hor...
1 comment:
Monday, May 03, 2010

Can Bristol Myers' Drug Pipeline Save Company?

›
Bristol-Myers Squibb (BMY-$25.31) derives almost 47 percent of its revenue from two key products: Plavix (sales of $6.1 billion in 2009),...

Forget Fed Loans -- Think Cool Cup Holders at GM

›
General Motors (GM) denies a deliberate intent to mislead the American public with recent televised advertisements, countering that terms o...
Tuesday, April 27, 2010

Could Bristol-Myers' Growth Flatline Post-Plavix?

›
In 2009, Bristol-Myers Squibb (BMY-$24.50) derived almost one-third of its total sales, or $6.1 billion, from the blood-clot inhibitor Plav...
Friday, April 23, 2010

Novartis' Search In a Post-Diovan World Continues

›
Findings from ASPIRE (Aliskiren Study in Post-MI Patients to Reduce Remodeling), one of 14 trials evaluating Novartis AG ’s (NVS-$51.97) Tek...
1 comment:
Monday, April 19, 2010

Talk of Oil Drilling at Chesapeake Energy Nothing But Gas

›
Chesapeake Energy’s (CHK-$23.50) near-term outlook calls for a shift in some production to oil and natural gas liquids, such as propane and...